Nicole Fett is a Dermatology physician affiliated with Oregon Health & Science University. OpenAlex indexes 102 publications with 2,160 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3303 SW Bond Ave
Ohsu Department Of Dermatology
Portland, OR 972394501
Telephone
503-418-3376Registry record last updated 23 Apr 2013.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20252 payments
- SANOFI-AVENTIS U.S. LLCProgram year20221 payment
- PFIZER INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
24.5%Tetracycline-class Drug8.7%Doxycycline Hyclate46%Doxycycline Monohydrate32%Minocycline Hcl22%Part D<11 patientsAzole Antifungal7.2%Ketoconazole100%Part D≥41 patients+ 4 more classes in this area
Dermatology
20.4%Corticosteroid13.9%Triamcinolone Acetonide100%Part D≥58 patientsInterleukin-4 Receptor alpha Antagonist5.1%Dupixent Pen58%Dupixent Syringe43%Part D<11 patients+ 1 more class in this area
Sensory organs
19.1%Corticosteroid19.1%Clobetasol Propionate60%Dexamethasone15%Hydrocortisone15%Betamethasone Dipropionate11%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Inflammatory and vaso-occlusive ulcers: Part I - Clinical presentation and diagnosis
Journal of the American Academy of Dermatology
2024 - Inflammatory and vaso-occlusive ulcers: Part II - Management
Journal of the American Academy of Dermatology
2024 - Recent Advances in Treatment of Systemic Sclerosis and Morphea
American Journal of Clinical Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Eric Orwoll, MD
Oregon Health & Science University
Aaron Caughey, MD
Oregon Health & Science University
Tomasz Beer, MD
Oregon Health & Science University
John Nutt, MD
Oregon Health & Science University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”